Avicanna exports cannabis flower to Switzerland

An anonymous director reports AVICANNA SUBSIDIARY COMPLETES EXPORT OF CBD DOMINANT CANNABIS FLOWER INTO SWITZERLAND Through Avicanna Inc.'s majority-owned subsidiary Santa Marta Golden Hemp SAS, the company has completed the first export of non-psychoactive cannabidiol-dominant cannabis flower to Switzerland. This export is a result of improvements directed by the company in 2024, when it improved internal practices and enhanced the local infrastructure at SMGH to expand the portfolio of Aureus-branded products with premium organic flower to meet the growing demand of medical cannabis flower in Europe and Australia. The company is currently producing a range of proprietary and premium CBD, cannabigerol and tetrahydrocannabinol genetics for these markets. This export included three proprietary varieties which are a part of the company's portfolio of registered cannabis varieties in Colombia. This also marks the 20th international market for Aureus-branded products and the 23rd market for all Avicanna products, which further validate the company's expertise in navigating complex regulatory processes for its commercialization efforts internationally. Avicanna carries out its operations in compliance with all applicable laws in the jurisdictions in which it operates. About Avicanna Inc. Avicanna is a commercial-stage international biopharmaceutical company focused on the advancement and commercialization of cannabinoid-based products and formulations for the global medical and pharmaceutical market segments. Avicanna has an established scientific platform, including research and development and clinical development, leading to the commercialization of more than 30 proprietary, evidence-based finished products and supporting four commercial-stage business pillars: Medical cannabis formulary (RHO Phyto): The formulary offers a diverse range of proprietary products, including oral, sublingual, topical and transdermal deliveries with varying ratios of cannabinoids, supported by continuing patient and medical community education. RHO Phyto is an established brand in Canada currently available nationwide across several channels and expanding into new international markets. Medical cannabis care platform (MyMedi): MyMedi is a medical cannabis care platform formed with the aim to better serve medical cannabis patients' needs and enhance the medical cannabis patients' journey. MyMedi is operated by Northern Green Canada Inc., and features a diverse portfolio of products and bilingual pharmacist-led patient support programs. MyMedi also provides specialty services to distinct patient groups such as veterans, and collaborates with public and private payers for adjudication and reimbursement. MyMedi provides educational resources to the medical community to facilitate the incorporation of medical cannabis into health care regimens. Pharmaceutical pipeline: Leveraging Avicanna's scientific platform, vertical integration and real-world evidence, Avicanna has developed a pipeline of proprietary, indication-specific cannabinoid-based candidates that are in various stages of clinical development. These cannabinoid-based candidates aim to address unmet needs in the areas of dermatology, chronic pain and various neurological disorders. Active pharmaceutical ingredients (Aureus Santa Marta): The company's majority-owned subsidiary Santa Marta Golden Hemp is a commercial-stage business dedicated to providing various forms of high-quality CBD, THC and CBG to the company's international partners for use in the development and production of food, cosmetics, medical and pharmaceutical products. SMGH also forms part of the company's supply chain, and is a source of reliable input products for its consumer retail, medical cannabis and pharmaceutical products globally. We seek Safe Harbor.